By Linda Thomas If you’ve been circling the world of inclusion body myositis for any length of time, you’ve probably heard the word biopsy spoken with a mix of reverence,…
Continue Reading
CAR T: A promising new frontier for myositis treatment
Compared to current therapies, chimeric antigen receptor (CAR) T cell therapy can not just suppress the immune system, but partially reset it, interrupting the loop of chronic inflammation and tissue…
Continue Reading
A treatment that’s almost too good to be true
Dermatologist Dr. David Fiorentino is excited about the possibilities of cell therapies to treat autoimmune conditions like dermatomyositis (DM). In collaboration with rheumatologists and bone marrow transplant specialists at Stanford…
Continue Reading
Vamorolone approved by FDA
Recently, the FDA announced the approval of a new drug, vamorolone, as a treatment for Duchenne muscular dystrophy (DMD), a genetic muscle disease that usually affects young boys. Understandably, this…
Continue Reading